T 0208/17 (Prognostic method for panitumumab/AMGEN) of 08.07.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T020817.20210708
- Date of decision
- 8 July 2021
- Case number
- T 0208/17
- Petition for review of
- -
- Application number
- 08742061.8
- IPC class
- G01N 33/574C12Q 1/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- K-ras mutations and anti-EGFR antibody therapy
- Applicant name
- Amgen Inc.
- Opponent name
- Strawman Limited
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Auxiliary request 3 - requirements of the EPC met - (yes)
Disclaimer - requirements of Article 123(2) EPC met - (yes) - Catchword
- -
- Citing cases
- T 2744/16
Order
For these reasons it is decided that:
The appeal is dismissed